A Randomized, Open-label, Single Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Cilnidipine 10 mg and Valsartan 160 mg After Oral Administration in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Cilnidipine (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Acronyms IDCV DDI
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jul 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea record: KCT0000763).
- 12 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.